MUMBAI, May 21 (Reuters) – Cadila Healthcare Ltd, among India’s top ten drugmakers, is in late-stage talks to buy smaller rival Claris Lifesciences Ltd for about 34 billion rupees ($534 million), the Economic Times newspaper reported on Thursday, citing sources aware of the talks.
India's Cadila Healthcare near deal to buy smaller rival Claris - paper
No comments:
Post a Comment